1. Quality of life after switching from well-controlled vitamin K antagonist to direct oral anticoagulant: Little to GAInN

   van Miert, J. H. A., Kooistra, H. A. M., Veeger, N. J. G. M., Westerterp, A., Piersma-Wichers, M. & Meijer, K., 14-Apr-2020, In : Thrombosis Research. 190, p. 69-75 7 p.

   Research output: Contribution to journal › Article › Academic › peer-review

2. Directe orale antistollingsmiddelen ook in Nederland een goede keus

   van Miert, J., Piersma-Wichers, M. & Meijer, K., 19-Jul-2019, In : Huisarts en Wetenschap. 1 p.

   Research output: Contribution to journal › Article › Professional

3. Choosing between continuing vitamin K antagonists (VKA) or switching to a direct oral anticoagulant in currently well-controlled patients on VKA for atrial fibrillation: a randomised controlled trial (GAInN)

   van Miert, J. H. A., Kooistra, H. A. M., Veeger, N. J. G. M., Westerterp, A., Piersma-Wichers, M. & Meijer, K., Aug-2019, In : British Journal of Haematology. 186, 3, p. e21-e23 3 p.

   Research output: Contribution to journal › Article › Academic › peer-review

4. Impact of Vitamin K Antagonists on Quality of Life in a Prospective Cohort of 807 Atrial Fibrillation Patients

   Kooistra, H. A. M., Piersma-Wichers, M., Kluin-Nelemans, H. C., Veeger, N. J. G. M. & Meijer, K., Jul-2016, In : Circulation: Cardiovascular Quality and Outcomes. 9, 4, p. 388-394 7 p.

   Research output: Contribution to journal › Article › Academic › peer-review

5. Risk of Bleeding and Thrombosis in Patients 70 Years or Older Using Vitamin K Antagonists

   Kooistra, H. A. M., Calf, A. H., Piersma - Wichers, G., Kluin-Nelemans, H. C., Izaks, G. J., Veeger, N. J. G. M. & Meijer, K., Aug-2016, In : Jama Internal Medicine. 176, 8, p. 1176-1183 8 p.

   Research output: Contribution to journal › Article › Academic › peer-review

View all (7) »